ICOTF: Targeting Stem Cells for Muscular Dystrophy Treatment
By David Bautz, PhD
OTC:ICOTF | TSX:MSCL.V
ARWR: License Agreement with GSK for ARO-HSD
By David Bautz, PhD
NASDAQ:ARWR
READ THE FULL ARWR RESEARCH REPORT
BLSTF: Blackstone Minerals Increases Exposure to Nickel with Investment in Flying Nickel; Private Placements to Provide AUD$60.3 million in Gross Proceeds
By Steven Ralston, CFA
OTC:BLSTF | ASX:BSX
READ THE FULL BLSTF RESEARCH REPORT
UCL: uCloudlink Returns to Revenue Growth as International Travel Starts to Pick up
By Lisa Thompson
NASDAQ:UCL
READ THE FULL UCL RESEARCH REPORT
BTAI: PDUFA Date for BXCL501 Extended to April 5, 2022
By David Bautz, PhD
NASDAQ:BTAI
READ THE FULL BTAI RESEARCH REPORT
POETF: POET Plans to Compete with a Superior Offering in the Medtech Wearables Market
By Lisa Thompson
OTC:POETF | TSX:PTK.V
READ THE FULL POETF RESEARCH REPORT
SQZ: Something New to Squeeze Into Your Portfolio
By John Vandermosten, CFA
NYSE:SQZ
READ THE FULL SQZ RESEARCH REPORT
CFRX: Direct Lytic Agents Show In Vitro Activity Against Gram-Negative Pathogens…
By David Bautz, PhD
NASDAQ:CFRX
READ THE FULL CFRX RESEARCH REPORT
BTAI: Preparations Underway for Commercial Launch of BXCL501; PDUFA Date of Jan. 5, 2022
By David Bautz, PhD
NASDAQ:BTAI
READ THE FULL BTAI RESEARCH REPORT
APLIF: PRESECO Trial Unsuccessful in COVID-19…
By David Bautz, PhD
OTC:APLIF | TSX:APLI.TO
READ THE FULL APLIF RESEARCH REPORT